Code | Name | Deposits | Targets | Ligand Type |
---|---|---|---|---|
PG4 | 2 | 2 | biological | |
PG4 | 26 | 26 | crystallization | |
PG4 | 2 | 2 | other | |
PEP | phosphoenolpyruvate | 1 | 1 | biological |
PEG | 21 | 19 | other | |
PEG | 122 | 99 | crystallization | |
PEG | 1 | 1 | biological | |
PE8 | 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol | 1 | 1 | crystallization |
PE5 | 3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol | 1 | 1 | crystallization |
PE3 | 11 | 8 | crystallization | |
PCA | 1 | 1 | crystallization | |
PCA | 3 | 2 | modified residue | |
PAF | pantoate | 1 | 1 | biological |
P6G | hexaethylene glycol | 10 | 7 | crystallization |
P68 | unknown | 1 | 1 | biological |
P5G | PEG | 1 | 1 | crystallization |
P41 | 1 | 1 | biological | |
P3G | 3,6,9,12,15-pentaoxaheptadecane | 1 | 1 | crystallization |
P3G | 3,6,9,12,15-pentaoxaheptadecane | 2 | 2 | other |
P33 | 3,6,9,12,15,18-hexaoxaicosane-1,20-diol | 3 | 3 | crystallization |